These constraints from the BTNX NTS are extremely relevant, as we observed e.g. etodesnitazene to own an identical in vitro potency and efficacy as fentanyl [7, thirteen] and as it may well possibly give PWUD a false perception of basic safety. Also, the detectability of nitazene analogues in drug samples can be impacted by solubility issues, as hi